About this episode

The episode features an interview with Joerg Ahlgrimm, CEO of SK pharmteco, discussing his journey in the pharmaceutical manufacturing sector and insights into the CDMO business.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Joerg Ahlgrimm, CEO SK pharmteco. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Joerg, covering: His journey from East Germany to leading global manufacturing organisations. How building and integrating acquired CDMO relationships ultimately led him to Lonza, where he helped scale the manufacturing network from fifteen to thirty five sites worldwide. What he learned about the “sticky” nature of the CDMO business, and the unforgiving reality of being a CDMO partner when execution does not go to plan. The leap from the scale and structure of Lonza in Basel to becoming employee number four at a CDMO start up in Philadelphia. Why his vision for a small molecule CDMO is to be easy to work with and present across the key global manufacturing regions. Why, despite the rise of blockbuster GLP one therapies, he believes the future lies in small volume, highly targeted, and complex to manufacture personalised medicines. Joerg Ahlgrimm is a global operations and supply chain executive with more than 25 years of leadership…

More episodes of Molecule to Market: Inside the outsourcing space

• Bora Live Panel - The Voice of the Customer · May 8, 2026 · 56 min
• Inside the mind of the CMO outsourcer · April 24, 2026 · 56 min
• The unconventional CEO · April 17, 2026 · 46 min
• The Indiana boy driving CGT development · April 10, 2026 · 47 min
• DCAT Live - Morgan Stanley CDMO CEO Dinner · April 3, 2026 · 46 min
• DCAT Live Panel - Stick or Twist with Capacity in Times of Uncertainty · March 30, 2026 · 52 min

Explore listener stats, chart rankings, contacts and more on the Molecule to Market: Inside the outsourcing space podcast page.